The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of…
dcorriganAugust 22, 2022
Duchenne muscular dystrophy (DMD) is a severe degenerative muscle disease caused by mutations in the…
dcorriganAugust 19, 2022
Biotechnology start-up GentiBio — a Seattle Children’s Research Institute spin-out — announced a multi-year collaboration with global pharmaceutical company…
dcorriganAugust 18, 2022
Several US agencies, including the National Oceanic and Atmospheric Administration (NOAA) and the Department of…
dcorriganAugust 18, 2022
The authors used novel ex vivo and in vivo models to characterize the effect of…
dcorriganAugust 17, 2022
BBI Member Dr. Fuki Hisama is a professor in the Department of Medical Genetics and…
dcorriganAugust 17, 2022
Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect…
dcorriganAugust 16, 2022
Prediction of treatment response has attracted growing attention in cancer research to improve clinical outcomes…
dcorriganAugust 16, 2022
Seattle startup HDT Bio will develop a nasal spray designed to counteract a wide range of respiratory…
dcorriganAugust 15, 2022
